Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC ®) in Women Living With HIV Aged 15-25 Years
Conditions: Human Papillomavirus Infection Interventions: Biological: Cervavac as three dose regimen; Biological: Cervavac as two dose regimen; Biological: Gardasil as three dose regimen Sponsors: Serum Institute of India Pvt. Ltd.; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Car-cinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
Conditions: Human Papilloma Virus; Sexual Assault; Sex Abuse Interventions: Diagnostic Test: smears Sponsors: Centre Hospitalier Universitaire Saint Pierre; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Conditions: Human Papillomavirus Infection Interventions: Other: Educational Intervention Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); National Institute on Minority Health and Health Disparities (NIMHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer; Persistent Infection Interventions: Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli); Other: No intervention; Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) Sponsors: Xiamen University; Xiamen Innovax Biotech Co., Ltd; Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Conditions: Human Papilloma Virus Interventions: Biological: Gardasil 9 Sponsors: University of Alabama at Birmingham; Merck Investigator Studies Program Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck; Oropharynx; Human Papillomavirus Viruses; Drug Therapy; Cancer Vaccine Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: PRGN-2009 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate the Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine
Conditions: Human Papillomavirus Infection Interventions: Biological: Nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc; University of Muhammadiyah Malang Hospital; Dr. M Djamil Hospital, Padang Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2024 Category: Research Source Type: clinical trials

A Phase III Trial to Evaluate the Immunogenicity and Safety of HPV Vaccine
Conditions: Human Papillomavirus Infection Interventions: Biological: nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil ®9 in Young Women
Conditions: Cervical Cancer; Condylomata Acuminata Interventions: Biological: Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli); Biological: Gardasil ®9 Sponsors: Xiamen Ophthalmology Center Affiliated to Xiamen University; Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials

HPV Vaccine Reminders - SEARCH II Study
Conditions: Human Papillomavirus Vaccination Interventions: Behavioral: Text Message/automated phone reminder Sponsors: Columbia University; Makerere University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease
Conditions: Human Papillomavirus Vaccine; Chronic Condition Interventions: Other: Questionnaire Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Conditions: Vaccine Reaction Interventions: Drug: Gardasil; Drug: Gardasil; Drug: Gardasil; Device: PharmaJet Stratis ® Needle-Free Injection System; Device: PharmaJet Tropis® Needle-Free Injection System Sponsors: PharmaJet, Inc.; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials

Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Conditions: HPV Infection Interventions: Other: Urine Sample Collection; Other: Self-collected Vaginal Swab; Other: Blood Samples Sponsors: International Vaccine Institute; London School of Hygiene and Tropical Medicine; Karolinska Institutet; Centers for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials